Pinned post
IRIL - IIT of response adapted approach to transplant ineligible #myeloma patients @MyelomaAust_MFA; a phase II study of #Isatuximab rescue for those responding poorly to #LenDex; Open to recruitment @StVincentsMelb; more sites coming. Minimize toxicity! Affordable health care!